Showing results (61-70 of 290) with videos related to
Sort By:
Pageof 29
Expert Review of Vaccines|February 7, 2007
Development of vaccines for Marburg hemorrhagic feverDaniel G Bausch, Thomas W GeisbertExpert Reviews in Molecular Medicine|September 24, 2004
Ebola virus: new insights into disease aetiopathology and possible therapeutic interventionsThomas W Geisbert, Lisa E HensleyPlos Pathogens|July 27, 2010
A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoatingChad E Mire, Judith M White, Michael A WhittScience Translational Medicine|August 22, 2014
Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNAEmily P Thi, Chad E Mire, Raul Ursic-Bedoya, et al.Thrombosis and Haemostasis|August 23, 2005
The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primatesLisa E Hensley, Thomas W GeisbertIscience|August 13, 2019
The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola VirusLuke D Jasenosky, Cristhian Cadena, Chad E Mire, et al.Nature|April 9, 2015
Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virusChad E Mire, Demetrius Matassov, Joan B Geisbert, et al.Expert Review of Vaccines|December 18, 2010
Progress in filovirus vaccine development: evaluating the potential for clinical useDarryl Falzarano, Thomas W Geisbert, Heinz FeldmannCurrent Opinion in Virology|February 14, 2013
Animal models for highly pathogenic emerging virusesDavid Safronetz, Thomas W Geisbert, Heinz FeldmannNature Microbiology|September 28, 2016
Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNAEmily P Thi, Amy C H Lee, Joan B Geisbert, et al.Pageof 29